Pzena Investment Management LLC Raises Stake in Cigna Group $CI

Pzena Investment Management LLC lifted its position in shares of Cigna Group (NYSE:CIFree Report) by 7.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 570,833 shares of the health services provider’s stock after purchasing an additional 40,992 shares during the quarter. Pzena Investment Management LLC’s holdings in Cigna Group were worth $157,110,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after acquiring an additional 4,738 shares during the period. Maj Invest Holding A S boosted its holdings in Cigna Group by 2.4% in the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after acquiring an additional 10,042 shares during the period. Providence Capital Advisors LLC boosted its holdings in Cigna Group by 1,016.8% in the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after acquiring an additional 7,748 shares during the period. National Pension Service boosted its holdings in Cigna Group by 3.2% in the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after acquiring an additional 21,203 shares during the period. Finally, Caprock Group LLC purchased a new position in Cigna Group in the 3rd quarter worth approximately $4,124,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 205,904 shares of company stock valued at $60,277,068 over the last three months. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

CI stock opened at $281.84 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market cap of $74.56 billion, a P/E ratio of 11.95, a P/E/G ratio of 0.99 and a beta of 0.30. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The stock’s 50 day simple moving average is $276.12 and its 200 day simple moving average is $276.03.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Wells Fargo & Company upped their price target on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Barclays increased their target price on Cigna Group from $303.00 to $310.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Cantor Fitzgerald increased their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.55.

View Our Latest Report on CI

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.